Perceive Bio’s $78 Million Series B Financing

Fenwick represented Perceive Bio on the deal.Perceive Bio, a biotech company pioneering novel technologies and therapeutics in ophthalmology, announced its $78 million Series B financing. The round…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here